Omni Partners’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Omni Partners’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-632,201	Closed	-$16M	–	41
2019 Q1	$16M	Buy	+632,201	New	+$11.2M	1.77%	11

Omni Partners's NITE Position: Q2 2019 in Review

Omni Partners sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 632,201 shares — an estimated $16M sold.

Omni Partners first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $16M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Omni Partners reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Omni Partners sold 632,201 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $16M.
Omni Partners first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
Omni Partners's Nightstar Therapeutics plc American Depositary Shares position peaked at $16M in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Omni Partners's 13F filing for Q2 2019, filed 14 Aug 2019.